Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurohormonal activation induces intracellular iron deficiency and mitochondrial dysfunction in cardiac cells
Marta Tajes, C. Díez-López, Cristina Enjuanes, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
Ridha I.S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 125-125
Open Access | Times Cited: 104
How can sodium–glucose cotransporter 2 inhibitors stimulate erythrocytosis in patients who are iron‐deficient? Implications for understanding iron homeostasis in heart failure
Milton Packer
European Journal of Heart Failure (2022) Vol. 24, Iss. 12, pp. 2287-2296
Open Access | Times Cited: 47
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure
Christiane E. Angermann, Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 11, pp. 1032-1043
Open Access | Times Cited: 33
The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases
Meng Li, Man Cui, Guoxia Li, et al.
Hormone and Metabolic Research (2024) Vol. 56, Iss. 10, pp. 683-696
Closed Access | Times Cited: 11
Critical re‐evaluation of the identification of iron deficiency states and effective iron repletion strategies in patients with chronic heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 6, pp. 1298-1312
Open Access | Times Cited: 7
Identification of three mechanistic pathways for iron-deficient heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Heart Journal (2024) Vol. 45, Iss. 26, pp. 2281-2293
Open Access | Times Cited: 6
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Elevated BUN Upon Admission as a Predictor of in-Hospital Mortality Among Patients with Acute Exacerbation of COPD: A Secondary Analysis of Multicenter Cohort Study
Jiarui Zhang, Yichun Qin, Chen Zhou, et al.
International Journal of COPD (2023) Vol. Volume 18, pp. 1445-1455
Open Access | Times Cited: 10
Proteomics and machine learning-based approach to decipher subcellular proteome of mouse heart
Haoyun Fang, Alin Rai, Seyed Sadegh Eslami, et al.
Molecular & Cellular Proteomics (2025), pp. 100952-100952
Open Access
Mitochondrial dysfunction in cardiovascular disease: investigating therapeutic approaches to enhance patient outcomes
Omar Elsaka
MGM Journal of Medical Sciences (2025) Vol. 12, Iss. 1, pp. 127-135
Open Access
Iron Deficiency Treatment in Heart Failure—Challenges and Therapeutic Solutions
Lucreția Anghel, Ciprian Dinu, Diana Pătraș, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 2934-2934
Open Access
Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives
Francesco Corradi, G Masini, Tonino Bucciarelli, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 14, pp. 2405-2420
Closed Access | Times Cited: 9
Expression of Iron Metabolism Proteins in Patients with Chronic Heart Failure
Bogna Kozłowska, Barbara Sochanowicz, Leszek Kraj, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 837-837
Open Access | Times Cited: 12
Association Between Different Insulin Resistance Indices and Heart Failure in US Adults With Diabetes Mellitus
Lirong Chen, Qian Lin, Yongming Liu
Annals of Noninvasive Electrocardiology (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 2
Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle
Carin Corovic Cabrera, Christoffer Frisk, Ulrika Löfström, et al.
International Journal of Cardiology (2023) Vol. 379, pp. 82-88
Open Access | Times Cited: 6
Iron Dyshomeostasis and Mitochondrial Function in the Failing Heart: A Review of the Literature
Seyed Ali Mousavi‐Aghdas, Ebrahim Farashi, Nasim Naderi
American Journal of Cardiovascular Drugs (2023) Vol. 24, Iss. 1, pp. 19-37
Closed Access | Times Cited: 4
Hemosiderin Accumulation in Liver Decreases Iron Availability in Tachycardia-Induced Porcine Congestive Heart Failure Model
Monika Kasztura, Liliana Kiczak, Urszula Pasławska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1026-1026
Open Access | Times Cited: 7
Anaemia, neurohormonal activation, and myocardial iron depletion in heart failure: can this vicious circle be broken?
Samira Lakhal‐Littleton
European Heart Journal (2024)
Closed Access | Times Cited: 1
Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes
Carles Díez‐López, Marta Tajes Orduña, Cristina Enjuanes Grau, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 4937-4937
Open Access | Times Cited: 8
Clinical and Molecular Aspects of Iron Metabolism in Failing Myocytes
Bogna Kozłowska, Barbara Sochanowicz, Leszek Kraj, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1203-1203
Open Access | Times Cited: 6
Iron chelation alleviates multiple pathophysiological pathways in a rat model of cardiac pressure overload
Mihai Lupu, Camelia Alexandra Coadă, Diana Tudor, et al.
Free Radical Biology and Medicine (2023) Vol. 200, pp. 1-10
Closed Access | Times Cited: 3
Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
María del Mar Ras-Jiménez, Raúl Ramos-Polo, Josep Francesch Manzano, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 8, pp. 1282-1282
Open Access | Times Cited: 2
The relationship between iron homeostasis and prognosis in patients with heart failure: a retrospective study based on the MIMIC IV database
Yuanhang Cai, Hao Jin, Lili Wang
Polskie Archiwum Medycyny Wewnętrznej (2024)
Open Access
The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes
Niels Grote Beverborg, Ridha I.S. Alnuwaysir, George Markousis‐Mavrogenis, et al.
European Journal of Heart Failure (2024)
Open Access
Iron deficiency and supplementation therapy in heart failure
Pedro Moliner, Josep Comín‐Colet
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 571-572
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top